爱康国宾被疑做“假体检”，张黎刚着急冲刺百亿营收

Core Viewpoint - The private health check giant Aikang Guobin is facing serious allegations of misdiagnosis and missed diagnoses, leading to significant public outcry and complaints from users [1][9][17]. Group 1: Allegations and Complaints - Aikang Guobin has been accused of failing to detect cancer risks in patients, with a notable case involving a lawyer who was diagnosed with late-stage cancer after ten years of annual check-ups [1][7]. - As of the report, Aikang Guobin has accumulated 1,220 complaints on the Black Cat Complaints platform, including issues related to inconsistent service fees, careless examination processes, and misleading consumption practices [3][5]. - The company has a history of similar allegations, with previous cases highlighting misdiagnosis and operational irregularities [10][12]. Group 2: Operational Issues - The company is criticized for significant gaps in its medical team qualifications and service procedures, which are seen as contributing factors to the reported misdiagnoses [5][23]. - Aikang Guobin's business model is under scrutiny, as it prioritizes rapid expansion and profitability over quality medical service, leading to potential risks in patient care [17][25]. - Reports indicate that a portion of newly hired staff at Aikang Guobin had not obtained their professional qualifications within six months of employment, raising concerns about the quality of care provided [23][24]. Group 3: Market Context and Future Plans - The health check industry in China is experiencing growth, with the market size reaching 235.6 billion yuan in 2023, reflecting a year-on-year increase of 10.6% [17][18]. - Aikang Guobin aims to achieve 10 billion yuan in revenue, with plans to expand its dental services and incorporate AI technology into health checks to address industry challenges [25][26]. - The company has been expanding rapidly, with 170 health check centers established across major cities in China, but this growth has come at the cost of service quality and patient safety [22][24].